Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s12016-010-8212-4.

Title:
Macrophagic Myofaciitis a Vaccine (alum) Autoimmune-Related Disease | Clinical Reviews in Allergy & Immunology
Description:
Macrophagic myofasciitis (MMF) is an immune-mediated condition first reported in 1998. MMF is characterized by post-vaccination systemic manifestations as well as local-stereotyped and immunologically active lesion in the site of inoculation (deltoid muscle). MMF systemic symptoms included myalgias, arthralgias, marked asthenia, muscle weakness, chronic fatigue, and fever. Recently, studies demonstrated that the local lesion is due to persistence for years at site of injection of an aluminum (Al(OH)3) adjuvant commonly used in human vaccines. Time elapsed from last immunization with an Al(OH)3-containing vaccine to muscle biopsy range from 3 months to 8 years; in rare cases, MMF may be diagnosed even 10 years post-vaccination. The discrepancy between the wide applications of aluminum hydroxide-containing vaccines and the very limited number of MMF cases reported may be resolved by observations suggesting that aluminum-containing vaccinations may trigger MMF in genetically susceptible subjects carrying the HLA-DRB1*01. Thus, MMF may be defined as an emerging novel condition that may be triggered by exposure to alum-containing vaccines, in patients with a specific genetic background, and this temporal association may be exhibited from a few months up to 10 years.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

article, google, scholar, macrophagic, pubmed, myofasciitis, cas, vaccine, shoenfeld, mmf, muscle, aluminum, access, aluminium, gherardi, privacy, cookies, content, disease, agmonlevin, yehuda, years, adjuvant, vaccines, information, publish, research, search, alum, israeli, blank, adjuvants, cherin, authier, vaccination, center, site, data, log, journal, allergy, myofaciitis, nancy, condition, subjects, genetic, open, discover, inflammatory, immunol,

Topics {✒️}

autoimmune-related disease published month download article/chapter vaccine adjuvant-related syndrome autoimmune-related disease laura schwarz-kip chair post-vaccination systemic manifestations article clinical reviews gherardi rk vaccine-derived aluminium hydroxide human macrophages full article pdf nancy agmon-levin privacy choices/manage cookies related subjects yehuda shoenfeld macrophagic myofasciitis unrelated sheba medical center article israeli european economic area subcutaneous pseudolymphoma caused multi-symptom conditions gulf war veterans inducing uric acid aluminic vaccine adjuvants macrophagic myofaciitis 10 years post-vaccination conditions privacy policy immunologically active lesion authier fj chronic fatigue syndrome immune-mediated condition check access instant access adjuvant commonly accepting optional cookies muscle biopsy range authors declare specific genetic background article log tel-aviv university recently identified condition journal finder publish author correspondence aluminum hydroxide agmon-levin article cite macrophagic myofasciitis mmf cases reported park yw aluminum phagocytosis

Questions {❓}

  • Guis S, Mattei JP, Nicoli F et al (2002) Identical twins with macrophagic myofasciitis: genetic susceptibility and triggering by aluminic vaccine adjuvants?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Macrophagic Myofaciitis a Vaccine (alum) Autoimmune-Related Disease
         description:Macrophagic myofasciitis (MMF) is an immune-mediated condition first reported in 1998. MMF is characterized by post-vaccination systemic manifestations as well as local-stereotyped and immunologically active lesion in the site of inoculation (deltoid muscle). MMF systemic symptoms included myalgias, arthralgias, marked asthenia, muscle weakness, chronic fatigue, and fever. Recently, studies demonstrated that the local lesion is due to persistence for years at site of injection of an aluminum (Al(OH)3) adjuvant commonly used in human vaccines. Time elapsed from last immunization with an Al(OH)3-containing vaccine to muscle biopsy range from 3 months to 8 years; in rare cases, MMF may be diagnosed even 10 years post-vaccination. The discrepancy between the wide applications of aluminum hydroxide-containing vaccines and the very limited number of MMF cases reported may be resolved by observations suggesting that aluminum-containing vaccinations may trigger MMF in genetically susceptible subjects carrying the HLA-DRB1*01. Thus, MMF may be defined as an emerging novel condition that may be triggered by exposure to alum-containing vaccines, in patients with a specific genetic background, and this temporal association may be exhibited from a few months up to 10 years.
         datePublished:2010-09-30T00:00:00Z
         dateModified:2010-09-30T00:00:00Z
         pageStart:163
         pageEnd:168
         sameAs:https://doi.org/10.1007/s12016-010-8212-4
         keywords:
            Macrophagic myofaciitis
            Vaccines
            Aluminum
            Autoimmunity
            Adjuvant
            Allergology
            Immunology
            Internal Medicine
         image:
         isPartOf:
            name:Clinical Reviews in Allergy & Immunology
            issn:
               1559-0267
               1080-0549
            volumeNumber:41
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press Inc
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Eitan Israeli
               affiliation:
                     name:Sheba Medical Center
                     address:
                        name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nancy Agmon-Levin
               affiliation:
                     name:Sheba Medical Center
                     address:
                        name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
                     name:Chaim Sheba Medical Center
                     address:
                        name:Department of Medicine ‘B’ and Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Miri Blank
               affiliation:
                     name:Sheba Medical Center
                     address:
                        name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yehuda Shoenfeld
               affiliation:
                     name:Sheba Medical Center
                     address:
                        name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
                     name:Chaim Sheba Medical Center
                     address:
                        name:Department of Medicine ‘B’ and Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
                     name:Tel-Aviv University
                     address:
                        name:Sackler Faculty of Medicine, Incumbent of the Laura Schwarz-Kip Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Aviv, Israel
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Macrophagic Myofaciitis a Vaccine (alum) Autoimmune-Related Disease
      description:Macrophagic myofasciitis (MMF) is an immune-mediated condition first reported in 1998. MMF is characterized by post-vaccination systemic manifestations as well as local-stereotyped and immunologically active lesion in the site of inoculation (deltoid muscle). MMF systemic symptoms included myalgias, arthralgias, marked asthenia, muscle weakness, chronic fatigue, and fever. Recently, studies demonstrated that the local lesion is due to persistence for years at site of injection of an aluminum (Al(OH)3) adjuvant commonly used in human vaccines. Time elapsed from last immunization with an Al(OH)3-containing vaccine to muscle biopsy range from 3 months to 8 years; in rare cases, MMF may be diagnosed even 10 years post-vaccination. The discrepancy between the wide applications of aluminum hydroxide-containing vaccines and the very limited number of MMF cases reported may be resolved by observations suggesting that aluminum-containing vaccinations may trigger MMF in genetically susceptible subjects carrying the HLA-DRB1*01. Thus, MMF may be defined as an emerging novel condition that may be triggered by exposure to alum-containing vaccines, in patients with a specific genetic background, and this temporal association may be exhibited from a few months up to 10 years.
      datePublished:2010-09-30T00:00:00Z
      dateModified:2010-09-30T00:00:00Z
      pageStart:163
      pageEnd:168
      sameAs:https://doi.org/10.1007/s12016-010-8212-4
      keywords:
         Macrophagic myofaciitis
         Vaccines
         Aluminum
         Autoimmunity
         Adjuvant
         Allergology
         Immunology
         Internal Medicine
      image:
      isPartOf:
         name:Clinical Reviews in Allergy & Immunology
         issn:
            1559-0267
            1080-0549
         volumeNumber:41
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press Inc
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Eitan Israeli
            affiliation:
                  name:Sheba Medical Center
                  address:
                     name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nancy Agmon-Levin
            affiliation:
                  name:Sheba Medical Center
                  address:
                     name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
                  name:Chaim Sheba Medical Center
                  address:
                     name:Department of Medicine ‘B’ and Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Miri Blank
            affiliation:
                  name:Sheba Medical Center
                  address:
                     name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yehuda Shoenfeld
            affiliation:
                  name:Sheba Medical Center
                  address:
                     name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
                  name:Chaim Sheba Medical Center
                  address:
                     name:Department of Medicine ‘B’ and Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
                  name:Tel-Aviv University
                  address:
                     name:Sackler Faculty of Medicine, Incumbent of the Laura Schwarz-Kip Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Aviv, Israel
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical Reviews in Allergy & Immunology
      issn:
         1559-0267
         1080-0549
      volumeNumber:41
Organization:
      name:Humana Press Inc
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Sheba Medical Center
      address:
         name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
      name:Sheba Medical Center
      address:
         name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
      name:Chaim Sheba Medical Center
      address:
         name:Department of Medicine ‘B’ and Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
      name:Sheba Medical Center
      address:
         name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
      name:Sheba Medical Center
      address:
         name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
      name:Chaim Sheba Medical Center
      address:
         name:Department of Medicine ‘B’ and Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
      name:Tel-Aviv University
      address:
         name:Sackler Faculty of Medicine, Incumbent of the Laura Schwarz-Kip Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Aviv, Israel
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Eitan Israeli
      affiliation:
            name:Sheba Medical Center
            address:
               name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
      name:Nancy Agmon-Levin
      affiliation:
            name:Sheba Medical Center
            address:
               name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
            name:Chaim Sheba Medical Center
            address:
               name:Department of Medicine ‘B’ and Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
      name:Miri Blank
      affiliation:
            name:Sheba Medical Center
            address:
               name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
      name:Yehuda Shoenfeld
      affiliation:
            name:Sheba Medical Center
            address:
               name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
            name:Chaim Sheba Medical Center
            address:
               name:Department of Medicine ‘B’ and Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
            name:Tel-Aviv University
            address:
               name:Sackler Faculty of Medicine, Incumbent of the Laura Schwarz-Kip Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Aviv, Israel
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
      name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
      name:Department of Medicine ‘B’ and Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel
      name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
      name:Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel
      name:Department of Medicine ‘B’ and Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel
      name:Sackler Faculty of Medicine, Incumbent of the Laura Schwarz-Kip Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Aviv, Israel
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(90)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.87s.